Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study

Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study

Background Concurrent chemoradiotherapy (CCRT) is an optimal recommended treatment for stage III non‐small cell lung cancer (NSCLC). Herein, we aimed to investigate the efficacy and safety of oral vinorelbine plus cisplatin with concomitant radiotherapy for stage III NSCLC. Methods This prospective,...

Full description

Bibliographic Details
Main Authors: Ping‐Chih Hsu, John Wen‐Chang Chang, Chun‐Chieh Wang, Chen‐Te Wu, Yu‐Ching Lin, Chih‐Liang Wang, Tin‐Yu Lin, Shih‐Hong Li, Yi‐Chen Wu, Scott Chih‐Hsi Kuo, Cheng‐Ta Yang, Chien‐Ying Liu, Chih‐Hung Chen
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Thoracic Cancer
Subjects:
Cisplatin
concurrent chemoradiotherapy
oral vinorelbine
stage III non‐small cell lung cancer
survival
Online Access:https://doi.org/10.1111/1759-7714.13125

Internet

https://doi.org/10.1111/1759-7714.13125

Similar Items